Immediate Impact
1 by Nobel laureates 80 standout
Citing Papers
Cellular and molecular mechanisms of skin wound healing
2024 Standout
Ulcerative colitis
2023 Standout
Works of Q. Li being referenced
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Q. Li | 306 | 216 | 63 | 87 | 17 | 349 | |
| Jingzhi Jiang | 293 | 267 | 38 | 97 | 10 | 380 | |
| Nancy Cross | 345 | 198 | 63 | 74 | 19 | 395 | |
| Bruno de Oliveira Rocha | 284 | 139 | 64 | 42 | 15 | 411 | |
| Hany Elmaraghy | 245 | 280 | 57 | 73 | 30 | 371 | |
| Jennifer Frueh | 286 | 127 | 64 | 50 | 14 | 355 | |
| Jai-Il Youn | 233 | 132 | 79 | 47 | 12 | 309 | |
| Giovanna Malara | 222 | 157 | 42 | 65 | 26 | 335 | |
| Ya‐Chu Tsai | 216 | 173 | 41 | 46 | 16 | 355 | |
| Klaudia Dopytalska | 217 | 142 | 32 | 36 | 16 | 329 | |
| Ting‐Shun Wang | 282 | 175 | 53 | 54 | 18 | 371 |
All Works
Loading papers...